Sanofi plans late-stage diabetes combo drug tests in 2014
PARIS (Reuters) - Sanofi aims to start late-stage tests for a pen device combining diabetes treatments Lantus and Lyxumia in the first half of 2014, according to slides posted on its website ahead of a presentation to investors on Monday.
The French drugmaker said in May it was stepping up the development of the fixed-combination pen to sidestep an earlier setback with a similar device and take advantage of the delayed U.S. launch of competitor Novo Nordisk's new insulin.
(Reporting by Elena Berton; Editing by James Regan)
- Air strike kills 15 civilians in Yemen by mistake: officials
- North Korea executes leader's powerful uncle in rare public purge |
- Insight: In Yemen, al Qaeda gains sympathy amid U.S. drone strikes
- Storm to cloak Midwest to Northeast in snow, freezing rain
- Twitter backtracks on block feature after users revolt |
Thousands line up to say goodbye to Nelson Mandela, whose body is lying in state in Pretoria. Slideshow